General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0VWKUZ
ADC Name
FeID1- (AL7-LP3)n
Synonyms
FeID1- (AL7-LP3)n
   Click to Show/Hide
Organization
REGENERON PHARMACEUTICALS, INC.
Drug Status
Investigative
Drug-to-Antibody Ratio
3.82
Structure
Antibody Name
FeID1
 Antibody Info 
Antigen Name
DNA-binding protein inhibitor ID-1 (ID1)
 Antigen Info 
Payload Name
CP1408
 Payload Info 
Linker Name
US20240269308A1 aHer2- (AL6-LP1)n Linker
 Linker Info 
Combination Type
LP3
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal inhibitory Concentration (lC50) 
121
nM
CVCL_0033
Breast adenocarcinoma
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) 121 nM Low ID1 expression (ID1+)
Method Description
The cell line used in the anti-proliferation assays was SK-BR-3, a human breast, adenocarcinoma (pleural effusion) cell line; The cells were grown in McCoy's 5a Medium+10% FBS. To run the assay, the cells (80 ul, 1000 cells) were added to each well in a 96-well plate and incubated for 24 hours at 37°C. with CO,. Next, the cells were treated with test compounds (20 ul) at various concentrations in appropriate cell culture medium (total volume, 0.1 mL). The control wells contain cells and the medium but lack the test compounds. The plates were incubated for 144 hours at 37°C. with CO,. CTG reagent was then added to the wells (100 il). After the plates were shaken for 10 min and then incubated for 10 min at room temperature, paste the clear bottom with white back seal and record luminescence with Envision. The inhibition % was calculated according to the following equation: inhibition %=[1- (assay-blank)/ (control-blank)|x100.

   Click to Show/Hide
In Vitro Model Breast adenocarcinoma SK-BR-3 cells CVCL_0033
References
Ref 1 Prodrugs of topoisomerase I inhibitor for ADC conjugations and methods of use thereof